Pii Presents Your Next Must-Read:

IND Strategy That Keeps You on Track: Parenteral Drug Development Built for the Fast Lane

Start Smart or Start Over

The path to IND submission for novel injectables is highly time-sensitive. Every delay eats into patent life and burns capital, so the ability to move quickly shapes today’s valuation and tomorrow’s market opportunity.

What’s inside?

Common causes of IND delays—and how to prevent unnecessary rework
The importance of early coordination across formulation, packaging, and fill-finish
How to integrate regulatory and QA considerations into your early development strategy
What to look for in a CDMO to support rapid IND and long-term growth
How Accelevate™ streamlines early development and accelerates IND readiness

This guide is designed for early development leaders navigating the time-critical path to IND submission—to help you spot what’s coming, shift gears faster, and avoid the detours that risk derailing IND.